ChiCTR2600120694 版本V1.0 版本创建时间2026/03/18 14:42:33 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600120694 

最近更新日期:

Date of Last Refreshed on:

2026-03-18 14:42:28 

注册时间:

Date of Registration:

2026-03-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

城乡差异视角下永川区中小学生过敏性鼻炎流行特征及多因素风险评估研究

Public title:

Study on the Epidemiological Characteristics and Multi-factor Risk Assessment of Allergic Rhinitis among Primary and Secondary School Students in Yongchuan District from the Perspective of Urban-rural Differences

注册题目简写:

English Acronym:

研究课题的正式科学名称:

城乡差异视角下永川区中小学生过敏性鼻炎流行特征及多因素风险评估研究

Scientific title:

Study on the Epidemiological Characteristics and Multi-factor Risk Assessment of Allergic Rhinitis among Primary and Secondary School Students in Yongchuan District from the Perspective of Urban-rural Differences

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李文君 

研究负责人:

李文君 

Applicant:

Li Wenjun 

Study leader:

Li Wenjun 

申请注册联系人电话:

Applicant telephone:

+86 13452450382

研究负责人电话:

Study leader's
telephone:

+86 23 85381665

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

329044139@qq.com

研究负责人电子邮件:

Study leader's E-mail:

329044139@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国重庆市永川区萱花路439号

研究负责人通讯地址:

中国重庆市永川区萱花路439号

Applicant address:

439 Xuanhua Road, Yongchuan District, Chongqing, China

Study leader's address:

439 Xuanhua Road, Yongchuan District, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属永川医院

Applicant's institution:

Yongchuan Hospital Affiliated to Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属永川医院

Affiliation of the Leader:

Yongchuan Hospital of Chongqing Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026EC0001

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属永川医院伦理委员会

Name of the ethic committee:

Ethics Committee of Yongchuan Hospital Affiliated to Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-01-09 00:00:00

伦理委员会联系人:

唐宇

Contact Name of the ethic committee:

Tang Yu

伦理委员会联系地址:

中国重庆市永川区萱花路439号

Contact Address of the ethic committee:

439 Xuanhua Road, Yongchuan District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 85381616

伦理委员会联系人邮箱:

Contact email of the ethic committee:

2992107908@qq.com

研究实施负责(组长)单位:

重庆医科大学附属永川医院

Primary sponsor:

Yongchuan Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

中国重庆市永川区萱花路439号

Primary sponsor's address:

439 Xuanhua Road, Yongchuan District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属永川医院

具体地址:

中国重庆市永川区萱花路439号

Institution
hospital:

Yongchuan Hospital of Chongqing Medical University

Address:

439 Xuanhua Road, Yongchuan District, Chongqing, China

经费或物资来源:

城乡差异视角下永川区中小学生过敏性鼻炎流行特征及多因素风险评估研究

Source(s) of funding:

Study on the Epidemiological Characteristics and Multi-factor Risk Assessment of Allergic Rhinitis a

研究疾病:

过敏性鼻炎  

Target disease:

Allergic rhinitis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

本项目聚焦于城乡差异视角下永川区中小学生过敏性鼻炎流行特征及多因素风险评估,其研究目的主要为: 1. 将儿童过敏性鼻炎的精准预防和干预措施提供参考依据; 2. 为永川区中小学生健康管理和公共卫生策略提供参考; 3. 为优化公共卫生资源配置、制定针对高风险人群的干预措施提供数据支撑等。  

Objectives of Study:

This project focuses on the epidemiological characteristics and multifactorial risk assessment of allergic rhinitis among primary and secondary school students in Yongchuan District from the perspective of urban-rural differences. The main research objectives are: 1. Provide reference for precise prevention and intervention measures for allergic rhinitis in children; 2. Provide reference for health management and public health strategies for primary and secondary school students in Yongchuan District; 3. Provide data support for optimizing the allocation of public health resources and developing intervention measures for high-risk populations.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 被随机抽选中的所在学校学生 2. 学生、学生家长获该研究的知情权,并自愿配合该项研究者 3. 学生或学生家长具备一定的阅读及理解能力,并能够配合调查问卷,回答问卷所需问题

Inclusion criteria

1. Randomly selected students from their respective schools; 2. Students and their parents have the right to be informed about the research and voluntarily cooperate with the researchers; 3. Students or their parents have a certain level of reading and comprehension ability, and are able to cooperate with survey questionnaires and answer the required questions.

排除标准:

1. 未被抽选中的所辖范围内中小学学生 2. 学生、学生家长未获该研究知情权,或获得知情权后不愿配合该项研究者 3. 学生或学生家长阅读及理解能力较弱,不能够配合调查问卷回答所需问题

Exclusion criteria:

1. Primary and secondary school students within the jurisdiction who have not been selected; 2. Students and their parents do not have the right to know about the study, or are unwilling to cooperate with the researcher after obtaining the right to know; 3. Students or their parents have weak reading and comprehension abilities and are unable to cooperate with the survey questionnaire to answer the required questions.

研究实施时间:

Study execute time:

From 2025-10-01 00:00:00 To 2027-10-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-03-20 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

城镇组

样本量:

1000

Group:

Urban Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

乡村组

样本量:

1000

Group:

Rural Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属永川医院 

单位级别:

三级甲等 

Institution
hospital:

Yongchuan Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

永川区中小学生在环境、遗传及生活方式等多因素作用 下,发生过敏性鼻炎的流行特征

指标类型:

主要指标

Outcome:

The epidemic characteristics of allergic rhinitis among primary and secondary school students in Yongchuan District under the influence of multiple factors such as environment, genetics and lifestyle

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

永川区中小学生过敏性鼻炎患病率、发展趋势及流行特 征是否存在城乡差异或地域性差异

指标类型:

主要指标

Outcome:

Are there any urban-rural or regional differences in the prevalence rate, development trend and epidemic characteristics of allergic rhinitis among primary and secondary school students in Yongchuan District

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

性别与神经源性炎症反应的相关性

指标类型:

主要指标

Outcome:

Correlation between sex and neurogenic inflammatory response

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Do not share

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

未涉及

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

not involve

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-03-18 14:42:28